On Biostatistics and Clinical Trials

CQ's web blog on the issues in biostatistics and clinical trials.

Saturday, May 30, 2009

Pharmacokinetics: Verify the Steady State Under Multiple Doses

›
For a multiple-dose regimen, the amount of drug in the body is said to have reached a steady state level if the amount or average concentrat...
Saturday, May 23, 2009

Statistical validation of the surrogate endpoints

›
A surrogate endpoint is intended to substitute for a clinical endpoint. A surrogate endpoint is expected to predict clinical benefit (or ha...
1 comment:
Friday, May 15, 2009

Imaging analysis in clinical trial

›
Medical imaging has now been a critical part in clinical trials. It can be used in many aspects of clinical trial process: 1) Disease dia...
Sunday, May 03, 2009

Adjustment for multiplicity

›
one of the issues in statistics field is the adjustment for multiplicity - adjustment of alpha level for multiple tests. The multiplicity ca...
3 comments:
Friday, May 01, 2009

Understanding person-year or patient-year

›
When I studied the public health many years ago, in occupational health class, the term 'person year' was pretty often used. Since t...
15 comments:
Saturday, April 25, 2009

Acronym related to Clinical trials in EU countries

›
In order to conduct a clinical trial in the EC, the sponsor must first submit a valid request for authorisation to the Competent Authority o...
1 comment:
Sunday, April 19, 2009

Risk management, pharmacoepidemiology, and pharmacovigilence

›
Risk Management: Risk management is the overall and continuing process of minimizing risks throughout a product's lifecycle to ...
2 comments:
Sunday, April 12, 2009

Effect Size

›
Effect size (ES) is a name given to a family of indices that measure the magnitude of a treatment effect. Unlike significance tests, these i...
1 comment:
Sunday, April 05, 2009

Least squares means (marginal means) vs. means

›
If you work with SAS, you probably heard and used the term 'least squares means' very often. Least squares means (LS Means) are actu...
35 comments:
Sunday, March 29, 2009

Jadad Scale to assess the quality of clinical trials

›
In a cost-effectiveness assessment report, a detail descriptions were provided for the approaches in choosing the clinical trial data for me...

Stratified randomization to achieve the balance of treatment assignment within each strata

›
Stratified randomization refers to the situation in which strata are constructed based on values of prognostic variables or baseline covaria...
1 comment:
Saturday, March 28, 2009

Too good to be true?

›
Typically, the regulatory authority requires two pivotal studied to demonstrate the efficacy. If the results from two studies show the confl...
Wednesday, March 18, 2009

Should expected clinical outcomes of the disease under study, which are efficacy endpoints, be reported as AEs/SAEs?

›
The paragraphs below are from the following website: http://firstclinical.com/journal/2008/0806_GCP35.pdf Some protocols instruct investigat...

Adverse events (AE), treatment emergent adverse events (TEAE), and adverse drug reaction (ADR)

›
There is some debate and inconsistencies regarding the definition of Adverse Drug Reactions. If you call it an adverse event, you may not ha...
28 comments:
Friday, March 06, 2009

What is the easiest way to start a meta analysis?

›
I used Revman program to do my meta analysis and generated the nice Forest plot two years ago. It worked for me very well at that time. Revm...

Biosimilar, Follow-up Biologics, Biogenerics, and Generic Biologics

›
Biosimilars or Follow-on biologics are terms used to describe officially approved new versions of innovator biopharmaceutical products, foll...
Sunday, March 01, 2009

iDMC, iSTAT, iDM, and more

›
I guess that the iDMC (stands for independent Data Monitoring Committee) has been used for a while, however, I first time heard the terms iS...
1 comment:
Saturday, February 28, 2009

Liability and Indemnification of data monitoring committee members

›
As stated in Demets ' paper "Liability issues for data monitoring committee members" (Clinical Trials 2004; 1: 525–531): In ra...
Friday, February 27, 2009

Confidence interval for correlation coefficient

›
When we perform the correlation analysis, we typically calculate the correlation coefficient and then test if this correlation coefficient i...
Thursday, February 19, 2009

Most testing for US drug industry's late-stage human trials done outside the country, study indicates

›
The Wall Street Journal (2/19, Wang) reports, "Most testing for the US drug industry's late-stage human trials is now done at site...
‹
›
Home
View web version

About Me

My photo
Web blog from Dr. Deng
Chapel Hill, NC, United States
邓春勤 A Medical Doctor turned into Biostatistician in Clinical Trial and Drug Development Industry
View my complete profile
Powered by Blogger.